Canopy Growth Corporation
Canopy Growth Corporation is a world leading diversified Canadian cannabis company. It operates a collection of diverse brands and curated strain varieties, supported by over half a million square feet of indoor and greenhouse production capacity. AusCann will work with Canopy to leverage its intellectual property, including its medical cannabis strains and products that are currently sold throughout Canada to over 24,000 patients.
Fundacion Daya is a non-profit Chilean organisation. Its objective is research and promotion of medical cannabis, aimed at relieving human suffering as well as advising on the design of public policies that promote the physical and well-being of people. The foundation's therapists advise patients about the use of medicinal cannabis and the different avenues of access to these therapies.
Fundacion Daya is AusCann’s joint venture partner in Chile and are the only licensed grower in Chile. In November 2016, AusCann and Fundacion Daya planted their first crop.
Phytoplant Research is a privately-owned Spanish company founded in 2008. The company specialises in developing the industrial chain of medicinal plants, from selection and breeding to registration, cultivation of registered varieties and obtaining derived products. Phytoplant Research focuses on research and development products that contain plant material and extracts, as well as essential and seed oils. These products represent significant economic potential for the pharmaceutical, nutraceutical and dermocosmetic industries.
AusCann accesses genetics, breeding, cultivation and extraction expertise from PhytoPlant.
Zelda Therapeutics is a California-founded biotechnology company focused on medical cannabis therapies with a strong Australian connection. Zelda has exclusive access to a substantial patient data set that demonstrates clinical efficacy of proprietary formulations in a range of diseases. Zelda was formed to fund clinical efficacy trials at leading clinical research organisations around the world based and through this data it can advance straight to clinical trials.
Zelda Therapeutics has signed an agreement with AusCann for the supply of medical grade cannabis for its Australian based trials.
Murdoch University is a public university in Perth, Western Australia, with campuses also in Singapore and Dubai. It is internationally recognised as a research-led institution with a flexible approach to learning.
AusCann have partnered with Murdoch University in a R&D collaboration for development of additional cannabis strains, with Phytoplant also contributing and further developing their strains.
Western Australian State Agricultural Biotechnology Centre (SABC)
The SABC is the collaborative university Centre for R&D in agricultural and veterinary biotechnology in Western Australia based at Murdoch University. It provides platform technologies and world class equipment and facilities for R&D in agricultural biotechnology to researchers from universities, state government and industry. Through AusCann’s research and development collaboration with Murdoch University to cultivate and develop targeting medical cannabis strains it will be working closely with the SABC’s team, led by Professor Mike Jones, and will have access to its state-of-the-art facilities.